Study of a new drug for advanced solid tumors
Part of Cancer clinical trials.
This trial tests a new oral drug called SIGX1094R for people with advanced solid tumors that have not responded to other treatments. The study will check if the drug is safe and how well it works, and it requires a tumor tissue sample to look for a specific marker.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have an advanced solid tumor that has stopped responding to standard treatments, or you cannot have standard treatments
- You can provide a small sample of your tumor tissue (old or new biopsy) for testing
- You are generally active (able to care for yourself and do light activities)
- Your liver, kidney, and blood cells are working well enough (will be checked with blood tests)
- You have not taken a FAK inhibitor before
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new experimental drug (called SYS6051) in people with advanced solid tumors that have not responded to standard treatments. The goal is to find out if the drug is safe and how well it works, and it might help control your cancer.
This trial tests a new drug called HSK39775 for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug is safe and effective for people who have few other options.
This trial is testing an investigational drug called SYS6077 to see if it is safe and tolerable for people with advanced solid tumors that have not responded to standard treatments. The goal is to find out if this drug is a safe option for patients who have run out of other choices.
This trial tests a new drug that targets a protein called MET found on some cancer cells. It may help people with certain advanced cancers that have not responded to other treatments.
This Phase 1 trial tests an experimental drug called GenSci139 for people with advanced solid tumors (cancers that have spread) that have not responded to standard treatments. The goal is to see if the drug is safe and how well it works.
This trial tests an experimental antibody drug called SIG001 for people with advanced solid tumors that haven't responded to standard treatments. It aims to see if the drug is safe and how well it works.
Hear when a new Advanced Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.